Lotte_profil-768x768-1-1.jpg

Lotte Stroebech

CEO, CSO, Founder, Doctor of Veterinary Medicine, PhD

Founder of ARTSMedia Denmark, Stroebech IVF Universe, Stroebech Media and, EmbryoTrans Biotech

Dr Stroebech was the first in the world to formulate and market a commercial serum-free ready-to-use media range for animal IVF, sold to IVFBioscience, UK. In 4 years the media was positioned as global #1 best performing IVF media and protocol.

Established and was head of the bovine IVF research laboratory at Origio, Cooper Surgical Denmark.

Academic work
Supervising international Phd students and Postdocs.

Research partner in research projects EliteOva, Elitesemen, Searmet, GIFT Brazil +20 publications within assisted reproductive technology and embryo physiology, co-attracted + 7 mio € in research funds within IVF related research projects.

Laboratory Director at IVF Laboratory at Faculty of Health and Medical Sciences
Department of Veterinary and Animal Sciences, Copenhagen Denmark.

Board positions
Chairman of the board of Danish society of Reproduction and Fetal Development, DSRF
Board member at International Embryo Technology Society, IETS
Association of Embryo Transfer society Europe, AETE

IVF Experience
Dr Stroebech has consulted with more than 300 IVF laboratories within animal research and animal production worldwide helping them get established or to improve results in existing laboratories.

phone light +45 25 32 08 25
envelope light lotte.stroebech@artsmedia.dk

Claus Yding Andersen

Founder, board member Doctor of Medical Science, Professor of Human Reproductive Physiology

Claus Yding Andersen is Scientific Director of the Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark and Professor of Human Reproductive Physiology with the Faculty of Health and Medical Sciences at the University of Copenhagen. He is educated as MSc (1979) and DMSc (1997) and has spent almost his entire career in reproductive medicine at LRB.

Professor Andersen was a member of the team that introduced IVF to Denmark in the mid-1980s and has worked as a consultant in more than 10 fertility clinics nationally and internationally. During the early years of IVF in Denmark, he produced and sold media for IVF treatment to all Danish IVF clinics and has been involved in media improvements throughout the years.

During the last twenty years he has headed a national program of cryopreservation of human ovarian and testicular tissue. He is considered one of the pioneers in this field and continues to expand the indications for the use of ovarian tissue cryopreservation in different clinical settings.

Professor Andersen’s major research contributions have been in ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue, human embryonic stem cells and development of new principles for ovarian stimulation including the introduction of the agonist trigger and novel approaches to luteal phase support.

He has published more than 400 peer-reviewed scientific papers. He is a much-requested international lecturer and is currently giving around 30 international lectures annually. His current H-index is 77 with more than 20.000 citations. He is currently chief editor on the Reproduction section in Frontiers in Endocrinology.

Claus Yding Andersen is Scientific Director of the Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark and Professor of Human Reproductive Physiology with the Faculty of Health and Medical Sciences at the University of Copenhagen. He is educated as MSc (1979) and DMSc (1997) and has spent almost his entire career in reproductive medicine at LRB.

Professor Andersen was a member of the team that introduced IVF to Denmark in the mid-1980s and has worked as a consultant in more than 10 fertility clinics nationally and internationally. During the early years of IVF in Denmark, he produced and sold media for IVF treatment to all Danish IVF clinics and has been involved in media improvements throughout the years.

During the last twenty years he has headed a national program of cryopreservation of human ovarian and testicular tissue. He is considered one of the pioneers in this field and continues to expand the indications for the use of ovarian tissue cryopreservation in different clinical settings.

Professor Andersen’s major research contributions have been in ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue, human embryonic stem cells and development of new principles for ovarian stimulation including the introduction of the agonist trigger and novel approaches to luteal phase support.

He has published more than 400 peer-reviewed scientific papers. He is a much-requested international lecturer and is currently giving around 30 international lectures annually. His current H-index is 77 with more than 20.000 citations. He is currently chief editor on the Reproduction section in Frontiers in Endocrinology.

Claus Yding Andersen - ARTS Media Denmark
about-us-martin.jpg

Martin Thomsen

CFO/COO

Martin Thomsen has 15 years of experience as CFO and COO for international companies, doing business in China, USA, UK, Germany, Ukraine and Scandinavia. Furthermore, Martin Thomsen has been head of establishing 3 start-ups to successful companies.
He has due diligence on the seller and buyer side as well as successful sale of a company to a private equity fund.

Martin thomsen was in the lead of the establishment of a factory in Hundested, Denmark for Chinese investors, for production of infant formula for sale in China. Responsible for factory and production.

Martin Thomsen has extensive experience in contact and negotiations with banks, suppliers, auditors and public authorities.

phone light +45 51921173
envelope light martin.thomsen@artsmedia.dk

Birthe Avery

Scientific Advisor Consultant, MD, PhD, DVSc.

Dr Avery is an international recognized pioneer within IVF and former associate professor (from the Veterinary Faculty, University of Copenhagen). Dr. Avery was for 27 years head of the IVF laboratory, and responsible for the research, which mainly included bovine, porcine and equine in vitro embryo technology. Dr Avery is a noteworthy embryologist, researcher and educator.

She became Doctor of Medicine, University Copenhagen, 1977 and PhD in Embryology, Royal Veterinary and Agricultural University, Copenhagen, 1991. And in 2007 Doctor in Veterinary Sciences, Royal Veterinary and Agricultural University, Copenhagen.

She has been a guest professor at Cornell University, New York, 1984, University Estate São Paulo, Jaboticabal, Brazil, 1993, University Wisconsin, Madison, 1996. Furthermore, she has been invited speaker to numerous national and international scientific conferences. She has worked from 2010 to currently, as Scientific Advisor and Consultant with Dr Stroebech optimizing and developing IVP media, and commercializing them into ready-to-use serum-free products. Thus, rendering a more accessible solution to IVP of bovine embryos and facilitated for more laboratories to implement the technique, without the trouble of media making and batch variation.

Dr Avery is an international recognized pioneer within IVF and former associate professor (from the Veterinary Faculty, University of Copenhagen). Dr. Avery was for 27 years head of the IVF laboratory, and responsible for the research, which mainly included bovine, porcine and equine in vitro embryo technology. Dr Avery is a noteworthy embryologist, researcher and educator.

She became Doctor of Medicine, University Copenhagen, 1977 and PhD in Embryology, Royal Veterinary and Agricultural University, Copenhagen, 1991. And in 2007 Doctor in Veterinary Sciences, Royal Veterinary and Agricultural University, Copenhagen.

She has been a guest professor at Cornell University, New York, 1984, University Estate São Paulo, Jaboticabal, Brazil, 1993, University Wisconsin, Madison, 1996. Furthermore, she has been invited speaker to numerous national and international scientific conferences. She has worked from 2010 to currently, as Scientific Advisor and Consultant with Dr Stroebech optimizing and developing IVP media, and commercializing them into ready-to-use serum-free products. Thus, rendering a more accessible solution to IVP of bovine embryos and facilitated for more laboratories to implement the technique, without the trouble of media making and batch variation.

Birthe Avery - ARTS Media Denmark
Ulrik Bangsbo Hansen - Board Vice President

Ulrik Bangsbo Hansen

Board Vice President

Ulrik Bangsbo Hansen is heading the Danish Life Science Sector Group at DLA Piper and has worked with the sector for almost 20 years.

The experience with the sector includes all kinds of corporate and commercial matters e.g. agreements concerning distribution, technology transfer, wholesalers, development, clinical trials, consultancy services, logistics, procurement etc.

Experience also includes regulatory and qualitative matters. Ulrik has been heading several complex restructuring projects and transactions.

Clients varies from some of the largest international companies to local MedTech and Biotech

Moreover, Ulrik has vast experience in corporate investments as well as the sale and purchase of enterprises and establishment of joint ventures. The assistance includes contract drafting, negotiating and due diligence where a large part of his advising concerns international issues.

Ulrik has served as chairman at Embryotrans ApS since 2016.

Ulrik regularly holds courses in company law, M&A and contract law.

China Medical International Health Ltd, HK, China,

Investor

Teste!